Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Bulk Drugs	3.37B
Bulk Drugs Growth	1.86%
Trading	277.01M
Trading Growth	46.71%
Exchange Rate Fluctuation	17.02M
Exchange Rate Fluctuation Growth	-57.31%
Research and Development	9.42M
Scrap	1.62M
Scrap Growth	-32.61%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
India	3.67B
India Growth	-0.77%